Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection

Evogene completes Phase 1 study of BMC128 in combination with Nivolumab

Cumberland Pharmaceuticals and Vanderbilt Health report data from Phase 2a trial of ifetroban to prevent cancer metastasis

Creatv Bio partners with Neovia Oncology to study multiple drug resistance in solid tumours

FDA accepts Genentech's giredestrant application for early-stage breast cancer

Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC

Anixa secures Canadian patent milestone for ovarian cancer vaccine

Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing

IBA launches Cyclone iKure for industrial-scale Astatine-211 production

Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy

Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026

Dizal presents positive NSCLC data for DZD6008 and golidocitinib at ASCO 2026

TiumBio presents Phase 2a interim data for Tosposertib plus pembrolizumab at ASCO 2026

ImmVira reports 100% CRR at 9 months in bladder carcinoma in situ with MVR-T3011

CARsgen presents long-term satri-cel follow-up results at 2026 ASCO Annual Meeting